IL33 and myocardial infarction: Flow cytometric analysis showed that in PcAT, there was a significant (P = 0.026) decrease in the abundance of ILC2 present in the group receiving sST2 compared with immunoglobulin G control, with a similar trend in heart-infiltrating cells, indicating that IL-33 likely drives the expansion of ILC2s after MI.